ERBB2 and breast neoplasm: It has been demonstrated that bitransgenic mice that express both activated Akt and ErbB2 in the mammary epithelium show increased breast tumor growth and a significant reduction in lung metastasis when compared to transgenic mice that express only activated ErbB2 [50].